RET Proto-oncogene, full gene analysis

Alphabetical Test listing

RET Proto-oncogene, full gene analysis-994

  
RET Proto-oncogene, full gene analysis
  
994
  
LAB994
  
MSO
  
CCHS
Congenital central hypoventilation syndrome
Familial Medullary Thyroid Cancer
FMTC
Hirschsrpung Disease
Hirschsprung's Disease
  

Confirmation of suspected clinical diagnosis of multiple endocrine neoplasia type A or B, Hirschsprung disease, or congenital central hypoventilation syndrome in patients with a suspected diagnosis of any of these conditions

  
  • A previous bone marrow transplant from an allogenic donor will interfere with testing.
    • Call 800-533-1710 for instructions for testing patients who have received a bone marrow transplant
  
EDTA whole blood
  
  
3.0 mL
  
1.0 mL
  

Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting

  

Lavender (EDTA), 4mL

  
ACD whole blood
  

Yellow ACD (A or B)

 

  

Immediately after collection, mix tube thoroughly by gentle inversion, 8 - 10 times, to prevent clotting

  

Yellow ACD (A or B)

  

Ambient (preferred) - 4 days

Refrigerated (OK)

Specimen preferred to arrive at Mayo within 96 hours of collection.

  
Mayo Clinic Laboratories (RETZZ): R-NX
  
Varies/weekly
  
3 - 4 weeks
  

Sequence Capture and Targeted Next-Generation Sequencing (NGS) followed by Polymerase Chain Reaction (PCR) and Sanger Sequencing

  

An interpretive report will be provided

  
81406
  
07/31/2015
  
11/18/2021